Table 1.
Demographic and clinical characteristics of patients on proton pump inhibitor (PPI) therapy, according to gender.
| Males | Females | p | Total | |
|---|---|---|---|---|
| Patients (n, %) | 377 (37.1) | 638 (62.9) | 1015 (100) | |
| Mean age ±SD (years) | 45.0 ± 14.8 | 47.9 ± 15.7 | 0.003 | 46.8 ± 15.4 |
| Range age (years) | 18–84 | 18–95 | 18–95 | |
| Body mass index (kg/m2) | 24.9 ± 3.6 | 23.9 ± 4.7 | 0.004 | 24.3 ± 4.4 |
| Cigarette smoking (%) | 18.6 | 17.9 | 0.061 | 18.2 |
| Daily alcohol intake (%) | 64.3 | 37.7 | 0.0001 | 47.5 |
| Autoimmune thyroiditis (%) | 3.4 | 19.3 | 0.0001 | 13.4 |
| HP eradication (%) | 15.6 | 23.2 | 0.002 | 20.4 |
| Gastric cancer familiarity (%) | 10.1 | 10.8 | 0.454 | 10.5 |
| NSAIDs use (%) | 15.4 | 21.8 | 0.007 | 19.4 |
| Aspirin use (%) | 8.8 | 6.6 | 0.125 | 7.4 |
NSAIDs: Non-steroidal antinflammatory drugs.